LeonaBio, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- LeonaBio, Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-09-30 was $12.00K.
- LeonaBio, Inc. stock issued during period, value, stock options exercised for the quarter ending 2023-06-30 was $11.00K, a 86.75% decline year-over-year.
- LeonaBio, Inc. stock issued during period, value, stock options exercised for the quarter ending 2023-03-31 was $99.00K, a 52.86% decline year-over-year.
- LeonaBio, Inc. stock issued during period, value, stock options exercised for the quarter ending 2022-06-30 was $83.00K, a 30.25% decline year-over-year.
- LeonaBio, Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $12.00K, a 92.81% decline from fiscal 2023.
- LeonaBio, Inc. stock issued during period, value, stock options exercised for fiscal 2023 was $167.00K, a 45.95% decline from fiscal 2022.
- LeonaBio, Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $309.00K.
- LeonaBio, Inc. stock issued during period, value, stock options exercised for fiscal 2020 was $544.00K, a 655.56% increase from fiscal 2019.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2024-12-31 | $12.00K 10-K · filed 2026-03-31 | |
| 2024-09-30 | $12.00K 10-Q · filed 2024-11-07 | |
| 2023-12-31 | $167.00K 10-K · filed 2025-02-27 | |
| 2023-06-30 | $11.00K 10-Q · filed 2024-11-07 | |
| 2023-03-31 | $99.00K 10-Q · filed 2024-11-07 | |
| 2022-12-31 | $309.00K 10-K · filed 2024-02-22 | |
| 2022-06-30 | $83.00K 10-Q · filed 2023-11-09 | |
| 2022-03-31 | $210.00K 10-Q · filed 2023-11-09 | |
| 2021-06-30 | $119.00K 10-Q · filed 2022-11-10 | |
| 2020-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $544.00K 10-K · filed 2022-03-28 |
| 2020-09-30 | $304.00K 10-Q · filed 2021-11-10 | $601.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $62.00K 10-Q · filed 2021-11-10 | $303.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-03-31 | $176.00K 10-Q · filed 2021-11-10 | |
| 2019-12-31 | $59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $72.00K 10-K · filed 2021-03-25 |
| 2019-09-30 | $6.00K 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |